Sign in
CompletedNo phase

The Impact of Frailty on Cardiopulmonary Resuscitation Adverse Outcomes in Patients Requiring Code Blue Activation

Key facts

Who runs it
Umraniye Education and Research Hospital
Where
Türkiye1 site in 1 countryChoose a country to see its sites
Trial code
Status
Completed
People taking part
2 people enrolled
Started
1 Dec 2025
Ended
30 May 2026
Type of study
Observational, 2 groups
Treatments tested
  • Edmonton frailty scale calculation
Record updated
8 October 2026

Who can take part

Age
18 years to 100 years
Sex
Women and men
Show the full registry criteria (2)Hide the full registry criteria

Who can take part

  • pediatric patients

Who cannot take part

  • pregnant patients

Where is this trial?

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

The aim of this study was to determine the independent association of frailty with cardiopulmonary resuscitation and predictive factors in patients triggering code blue response

The 2 groups in the trial

  • Edmonton frailty scale ≥ 7

    The frailty status of the patients will be assessed using the Edmonton frailty scale. According to the Edmonton frailty scale; * (0-5): not frail * (6-7): sensitive * (8-9): slightly fragile * (10-11): moderately fragile, * (12-17): extremely fragile

    Treatment: Edmonton frailty scale calculation

  • Edmonton frailty scale below 7

    The frailty status of the patients will be assessed using the Edmonton frailty scale. According to the Edmonton frailty scale; * (0-5): not frail * (6-7): sensitive * (8-9): slightly fragile * (10-11): moderately fragile, * (12-17): extremely fragile

    Treatment: Edmonton frailty scale calculation

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Record updated
8 October 2026